04/21/2025
4:43 PM | Coric Vlad (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:40 PM | Coric Vlad (Reporting)
Royalty Pharma (Issuer)
| Form 3/A | |
04/21/2025
4:18 PM | Royalty Pharma (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/11/2025
8:15 AM | Royalty Pharma (Filer)
| Form DEFA14A | |
04/11/2025
7:45 AM | Royalty Pharma (Filer)
| Form DEFM14A | |
04/11/2025
7:50 AM | Royalty Pharma (Filer)
| Form ARS | |
04/11/2025
7:53 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/10/2025
3:17 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
04/10/2025
3:06 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2025
4:45 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
4:46 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for RPRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Royalty Pharma and its competitors with MarketBeat's FREE daily newsletter. |
03/05/2025
4:25 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
02/21/2025
3:30 PM | Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
| Form SCHEDULE 13D/A | |
02/13/2025
5:03 AM | Royalty Pharma (Filer)
| Form PREM14A | |
02/12/2025
8:30 AM | FMR LLC (Filed by)
Royalty Pharma (Subject)
| Form SCHEDULE 13G/A | |
02/11/2025
6:38 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
4:12 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/16/2025
4:15 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/15/2025
4:04 PM | Royalty Pharma (Subject)
| Form 425 | |
01/13/2025
7:40 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/13/2025
7:42 AM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/10/2025
4:21 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
4:26 PM | Royalty Pharma (Filer)
| Form DEFA14A | |
01/10/2025
6:47 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/31/2024
3:05 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/08/2024
2:15 PM | MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
| Form SC 13G/A | |
11/06/2024
8:24 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/06/2024
6:35 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/30/2024
4:07 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:08 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/27/2024
7:39 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
6:17 PM | Royalty Pharma (Issuer)
Urist Marshall (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:19 PM | Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
6:20 PM | Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
8:02 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:20 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:04 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/29/2024
3:30 PM | Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
| Form SC 13D/A | |
06/28/2024
4:09 PM | Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
4:12 PM | Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
7:03 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
What President Trump’s Executive Order 14154 means for your money (Ad) Nearly $3 trillion disappeared from the stock market on Thursday morning.
According to Whitney Tilson - a former hedge fund manager who predicted the dotcom crash, the housing crisis, and the 2022 tech stock bloodbath - a little-known executive order from the President's first day in office could spark a paradigm-shift that will likely catch millions of Americans off guard. But because of the massive changes impacting U.S. stocks, Tilson has agreed to publish his latest fi |
06/10/2024
3:16 PM | LOVE TED W (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:21 PM | Norden Gregory (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
4:06 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
8:13 AM | Royalty Pharma Holdings Ltd. (Filer)
Royalty Pharma (Filer)
| Form 424B5 | |
06/03/2024
7:39 AM | Royalty Pharma Holdings Ltd. (Filer)
Royalty Pharma (Filer)
| Form S-3ASR | |
05/29/2024
4:25 PM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/16/2024
4:42 PM | Hite Christopher (Reporting)
Royalty Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2024
8:01 AM | Royalty Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
6:17 AM | Royalty Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
